Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    24332516 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer
Condition: Non-melanomatous Skin Cancer
Interventions: Drug: imiquimod;   Procedure: conventional surgery
2 Not yet recruiting Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma
Condition: Nodular Basal Cell Carcinoma
Interventions: Drug: Imiquimod 5% cream with prior curettage;   Procedure: Standard surgical excision

Indicates status has not been verified in more than two years